Evidence map›Paper›PMID 41837745›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences2026

Mild Behavioral Impairment: A Population-Based Study.

Maria Vassilaki, Jeremy A Syrjanen, Janina Krell-Roesch, Jonathan Graff-Radford, Prashanthi Vemuri, Julie A Fields, Walter K Kremers, Clifford R Jack, David S Knopman, Constantine G Lyketsos and 2 more

Abstract read
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria VassilakiDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Jeremy A SyrjanenDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Janina Krell-RoeschDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, Rochester, MN.
Prashanthi VemuriDepartment of Radiology, Mayo Clinic, Rochester, MN.
Julie A FieldsDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Walter K KremersDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, MN.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, MN.
Constantine G LyketsosDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview and Medicine, Baltimore.
Ronald C PetersenDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Yonas E GedaDepartment of Neurology and the Franke Global Neuroscience Education Center, Barrow Neurological Institute, Phoenix.

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$33.5M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ DementiaR01AG057708 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GEDA, YONAS E · 2018 to 2022
$1.7M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR21AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2018 to 2019
$437k
NIA NIH HHS P30 AG062677NIA NIH HHS P30 AG066507NIA NIH HHS R01 AG041851NIA NIH HHS R01 AG057708NIA NIH HHS R21 AG058738NIA NIH HHS R33 AG058738NIA NIH HHS R37 AG011378NIA NIH HHS U01 AG006786
6 · The paper itself

Abstract

objectiveThe authors conducted a population-based investigation of mild behavioral impairment (MBI) in the Mayo Clinic Study of Aging setting. MBI refers to new onset of neuropsychiatric symptoms (NPS) among adults ages ≥50 that is not due to a psychiatric disorder and that may be a precursor of cognitive decline or dementia.

methodsThe Neuropsychiatric Inventory Questionnaire was used in a cross-sectional study of participants ≥50 years without dementia to assess for NPS. Linear and logistic regression models were estimated and adjusted for age, sex, and education.

resultsThe study sample comprised 2,713 participants (mean±SD age=74.6±9.5 years, 47% women). Overall, 11% of the participants had MBI at the first follow-up; 2,498 were cognitively unimpaired (10% of whom had MBI), and 215 had mild cognitive impairment (MCI; 29% of whom had MBI). Having MBI was associated with significantly higher odds of MCI (OR=3.47, 95% CI=2.46-4.84) and lower cognitive scores. Severe MBI was associated with even higher MCI odds (OR=5.15, 95% CI=2.73-9.37) and lower cognitive scores.

conclusionsIn this study of older adults, participants with MCI were almost three times more likely than cognitively unimpaired participants to have MBI. Having MBI was associated with increased odds of having MCI and lower cognitive scores.

Indexed as

Cognitive DysfunctionAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeuropsychological TestsCognitive DisordersEpidemiology of Neuropsychiatric DisordersMild Behavioral ImpairmentNeuropsychiatric Symptoms

Identifiers

PMID41837745
PMCPMC12994854

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.